These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35855749)

  • 1. Erratum: GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma [Corrigendum].
    Int J Nanomedicine; 2022; 17():3073-3074. PubMed ID: 35855749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma.
    Li Y; Wu J; Lu Q; Liu X; Wen J; Qi X; Liu J; Lian B; Zhang B; Sun H; Tian G
    Int J Nanomedicine; 2022; 17():2559-2575. PubMed ID: 35698562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum: Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum].
    Int J Nanomedicine; 2019; 14():8753-8754. PubMed ID: 31806969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum].
    Int J Nanomedicine; 2020; 15():8293-8294. PubMed ID: 33149576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-Ligand-Modified Liposomes Co-Loaded with Anti-Angiogenic and Chemotherapeutic Drugs for Inhibiting Tumor Angiogenesis and Metastasis.
    Wang F; Li Y; Jiang H; Li C; Li Z; Qi C; Li Z; Gao Z; Zhang B; Wu J
    Int J Nanomedicine; 2021; 16():4001-4016. PubMed ID: 34135585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Synthesis, Characterization, and in vitro Evaluation of Curcumin-Loaded Albumin Nanoparticles Surface-Functionalized with Glycyrrhetinic Acid [Corrigendum].
    Int J Nanomedicine; 2021; 16():4371-4372. PubMed ID: 34234431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Tat-Functionalized Liposomes for the Treatment of Meningitis: An in vitro Study [Corrigendum].
    Int J Nanomedicine; 2020; 15():9317. PubMed ID: 33268985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Corrigendum].
    Int J Nanomedicine; 2021; 16():1927. PubMed ID: 33707947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice [Corrigendum].
    Int J Nanomedicine; 2021; 16():469-470. PubMed ID: 33488081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Application of Multifunctional Targeting Epirubicin Liposomes in the Treatment of Non-Small-Cell Lung Cancer [Corrigendum].
    Int J Nanomedicine; 2021; 16():7495-7496. PubMed ID: 34785896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC [Corrigendum].
    Int J Nanomedicine; 2021; 16():8067-8068. PubMed ID: 34938073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis [Corrigendum].
    Int J Nanomedicine; 2021; 16():6203-6204. PubMed ID: 34522096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-Delivery of Curcumin and Capsaicin by Dual-Targeting Liposomes for Inhibition of aHSC-Induced Drug Resistance and Metastasis.
    Qi C; Wang D; Gong X; Zhou Q; Yue X; Li C; Li Z; Tian G; Zhang B; Wang Q; Wei X; Wu J
    ACS Appl Mater Interfaces; 2021 Apr; 13(14):16019-16035. PubMed ID: 33819006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Carbon Nanotubes: Smart Drug/Gene Delivery Carriers [Corrigendum].
    Int J Nanomedicine; 2021; 16():7283-7284. PubMed ID: 34737565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Preparation of AS1411 Aptamer Modified Mn-MoS
    Int J Nanomedicine; 2023; 18():505-507. PubMed ID: 36733408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives [Corrigendum].
    Int J Nanomedicine; 2021; 16():5099. PubMed ID: 34349509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature [Corrigendum].
    Int J Nanomedicine; 2022; 17():183-184. PubMed ID: 35046653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: Silver Nanoparticles as Chlorhexidine and Metronidazole Drug Delivery Platforms: Their Potential Use in Treating Periodontitis [Corrigendum].
    Int J Nanomedicine; 2023; 18():1613-1614. PubMed ID: 37020687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Construction and in vivo/in vitro Evaluation of a Nanoporous Ion-Responsive Targeted Drug Delivery System for Recombinant Human Interferon α-2b Delivery [Corrigendum].
    Int J Nanomedicine; 2021; 16():4191-4192. PubMed ID: 34168451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting "substance P-hepatic stellate cells-hepatocellular carcinoma" axis.
    Li Z; Wang F; Li Y; Wang X; Lu Q; Wang D; Qi C; Li C; Li Z; Lian B; Tian G; Gao Z; Zhang B; Wu J
    Biomaterials; 2021 Sep; 276():121003. PubMed ID: 34273686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.